These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Cardiac responses after norepinephrine-induced ventricular hypertrophy in rats. Brown L, Sernia C, Newling R, Fletcher P. J Cardiovasc Pharmacol; 1992 Aug; 20(2):316-23. PubMed ID: 1381025 [Abstract] [Full Text] [Related]
29. Calcium sensitivity of isometric tension in intact papillary muscles and chemically skinned trabeculae in different models of hypertensive hypertrophy. Pedroni P, Perez GN, Mattiazzi A. Cardiovasc Res; 1990 Jul; 24(7):584-90. PubMed ID: 2145071 [Abstract] [Full Text] [Related]
30. Desensitization of myocardial but not coronary VIP receptor-mediated responses in dogs. Anderson FL, Kralios AC, Hershberger R, Bristow MR. Am J Physiol; 1988 Sep; 255(3 Pt 2):H601-7. PubMed ID: 2843056 [Abstract] [Full Text] [Related]
31. Altered inotropic responsiveness and gene expression of hypertrophied myocardium with captopril. Brooks WW, Bing OH, Boluyt MO, Malhotra A, Morgan JP, Satoh N, Colucci WS, Conrad CH. Hypertension; 2000 Jun; 35(6):1203-9. PubMed ID: 10856264 [Abstract] [Full Text] [Related]
37. Inotropic response of the rat heart during development and regression of triiodothyronine-induced hypertrophy. Lortet S, Zimmer HG, Rossi A. J Cardiovasc Pharmacol; 1989 Nov; 14(5):707-12. PubMed ID: 2481184 [Abstract] [Full Text] [Related]
38. Properties of adenylate cyclase in the cardiovascular tissues of renal hypertensive rats. Sharma RV, Kemp DB, Gupta RC, Bhalla RC. J Cardiovasc Pharmacol; 1982 Nov; 4(4):622-8. PubMed ID: 6181337 [Abstract] [Full Text] [Related]